Table 2.

Remission rate and treatment outcome on CCG-2891 and CCG-2961 by ethnicity



CCG-2891

CCG-2961
Remission rate
6-year survival
6-year EFS
Remission rate
3-year survival
3-year EFS

%
P
% (2 SE)
P
% (2 SE)
P
%
P
% (2 SE)
P
% (2 SE)
P
White   77.90   .518   48 (4)   .003   36 (4)   .077   85.6   .829   60 (4)   .007   46 (4)   .018  
Black   77.50   .956   34 (10)   .007   25 (9)   .044   76.8   .517   45 (12)   .007   28 (11)   .006  
Hispanic   70.90   .144   37 (9)   .016   33 (9)   .191   87.3   .786   51 (8)   .065   40 (8)   .101  
Asian
 
88.00
 
.322
 
54 (21)
 
.847
 
44 (20)
 
.503
 
83.3
 
.363
 
54 (20)
 
.648
 
52 (21)
 
.617
 


CCG-2891

CCG-2961
Remission rate
6-year survival
6-year EFS
Remission rate
3-year survival
3-year EFS

%
P
% (2 SE)
P
% (2 SE)
P
%
P
% (2 SE)
P
% (2 SE)
P
White   77.90   .518   48 (4)   .003   36 (4)   .077   85.6   .829   60 (4)   .007   46 (4)   .018  
Black   77.50   .956   34 (10)   .007   25 (9)   .044   76.8   .517   45 (12)   .007   28 (11)   .006  
Hispanic   70.90   .144   37 (9)   .016   33 (9)   .191   87.3   .786   51 (8)   .065   40 (8)   .101  
Asian
 
88.00
 
.322
 
54 (21)
 
.847
 
44 (20)
 
.503
 
83.3
 
.363
 
54 (20)
 
.648
 
52 (21)
 
.617
 

For statistical analysis, white patients were compared with a combined group of other ethnic groups, and other ethnic groups were individually compared with white patients alone. Remission rate was defined from start of therapy to the end of course 2; treatment outcome (OS, EFS) was estimated from end of 2 courses.

SE indicates standard error.

or Create an Account

Close Modal
Close Modal